291.4 ๐ ็ซ ๆซ้่จ Summary
291.4.1 ๐ ไธๅฅ่ฉฑ็ธฝ็ต
ๅฆๅจ CV ็็ โ ่ก้ โ 40-50%ใCO โ 30-50%ใSVR โ 20%ใHR โ 10-20๏ผpeak stress 28-32 ้ฑ + L&D + ็ขๅพ 2 ้ฑ๏ผrisk stratification mWHO 1-4๏ผ4 = ็ฆๆทๅญ๏ผEisenmengerใsevere PAHใsevere ASใsingle ventใMarfan aorta > 45 mmใEF < 30%ใsevere MS๏ผ๏ผๅฆๅจ ๆ้ๅคง CV ็พ็ ๏ผpreeclampsia/eclampsia๏ผmagnesium + ๆงๅฃ + delivery๏ผใperipartum cardiomyopathy (PPCM, HF in last month-5 mo postpartum)ใaortic dissection๏ผMarfan + 3rd trimester/postpartum ้ซ็ผ๏ผใSCAD๏ผperipartum, conservative management๏ผ๏ผ็จ่ฅๅฎๅ จ: labetalol/methyldopa/nifedipine/hydralazine/digoxin/LMWH/ไฝๅ้ ASA ๅฎๅ จ๏ผ็ฆๅฟ: ACEi/ARB/MRA/warfarin 1st trimester/DOAC/atenolol/amiodarone/statins/ETAsใ
291.4.2 ๐ ๆฒป็็ฒพ่ฆ
- HTN/preeclampsia๏ผlabetalol๏ผIV/PO๏ผใnifedipine ERใmethyldopaใhydralazine๏ผsevere โ IV labetalol + magnesium sulfate
- PPCM๏ผๆจๆบ HF therapy ๆน่ฏ็๏ผloop + carvedilol/metoprolol + hydralazine/ISDN + LMWH if EF < 35%๏ผ๏ผbromocriptine ๅฏ้ธ๏ผpostpartum ๆน ACEi/ARB
- Mechanical valve๏ผLMWH 1st trimester + warfarin 2nd-3rd + UFH/LMWH peripartum
- VTE / PE๏ผLMWH ร 6 wk postpartum minimum
- Arrhythmia๏ผvagal + adenosine (SVT)ใmetoprololใdigoxin๏ผ้ฟๅ amiodarone
291.4.3 ๐ฏ ็ง้ซๅธซ็่ๅๆ้
- Peak hemodynamic stress = 28-32 wk + L&D + ็ขๅพ 2 ้ฑ๏ผ้ซๆญปไบก้ขจ้ชๆๆฎต๏ผ
- mWHO IV ็ตๅฐ้ฟๅญ๏ผEisenmengerใsevere PAHใsevere AS๏ผsymptomatic or not๏ผใsingle ventใMarfan > 45 mmใBAV > 50 mmใEF < 30%ใsevere MSใprior PPCM with ไธๅฏ้ LV dysfunction
- PPCM ็นๅพต๏ผlate pregnancy-5 mo postpartum + LVEF < 45% + ๆ้คๅ ถไปๅๅ ๏ผAfrican American 4-10x โ๏ผbromocriptine controversial๏ผrecurrence rate 30-80%
- preeclampsia๏ผBP โฅ 140/90 + proteinuria/end-organ damage after 20 wk๏ผmagnesium sulfate for seizure prophylaxis๏ผdelivery ๆๆฏ definitive treatment
- aspirin 81-150 mg/d from 12-16 wk ็จๆผ high-risk preeclampsia ้ ้ฒ๏ผASPRE 2017๏ผ
- mechanical valve anticoag๏ผ1st trim LMWH๏ผwarfarin embryopathy 5-25%๏ผโ 2nd-3rd trim warfarin๏ผๅฆๅ้ โค 5 mg/d ้ขจ้ช่ผไฝ๏ผโ ็ขๆ UFH/LMWH
- pregnancy SCAD๏ผ1-4% of pregnancy MI๏ผconservative > PCI๏ผhigh re-dissection rate๏ผ๏ผavoid stress testing in recovery
- ็ตๅฐ็ฆๅฟ่ฅ๏ผACEi/ARB/MRA/aliskirenใwarfarin 1st trimesterใDOACsใatenolol๏ผIUGR๏ผใamiodaroneใETAs๏ผteratogenic๏ผใriociguatใsotatercept
- ๅฎๅ จ่ฅ๏ผlabetalol๏ผfirst-line HTN๏ผใmethyldopaใnifedipine ERใhydralazineใdigoxinใadenosineใLMWHใlow-dose ASA
- Marfan + ไธปๅ่ > 4.5 mm๏ผpre-pregnancy ไฟฎ่ฃ๏ผไธไฟฎ่ฃ็่ฉฑ่ๆ ฎ cesarean delivery + ฮฒ-blocker continuation